Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience()

BACKGROUND: Long-term data on the effectiveness and safety of the booster dose of anti-SARS-CoV-2 vaccines in people affected by multiple sclerosis (pwMS) are lacking, hence a retrospective monocentric study exploring these issues was undertaken. MATERIALS AND METHODS: PwMS who had received the boos...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertozzi, Andrea, Mariottini, Alice, Marchi, Leonardo, Cristinzi, Maria Di, Nistri, Riccardo, Damato, Valentina, Mechi, Claudia, Barilaro, Alessandro, Massacesi, Luca, Repice, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957336/
https://www.ncbi.nlm.nih.gov/pubmed/36889098
http://dx.doi.org/10.1016/j.msard.2023.104582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957336/
https://www.ncbi.nlm.nih.gov/pubmed/36889098
http://dx.doi.org/10.1016/j.msard.2023.104582

Ejemplares similares